Center for Aphasia Research & Treatment, Rehabilitation Institute of Chicago
Chicago, Illinois, 60611, United States
NCT Number: NCT01597037
The purpose of this study is to evaluate how changing different conditions of the speech-language treatment (such as cues, feedback, complexity and practice schedule) affects the language outcome of study subjects with aphasia (i.e., difficulty with the comprehension and expression of spoken and written language) following a stroke.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60611, United States
Stroke is the third leading cause of death and the most common cause of disability in the United States. According to the American Stroke Association, the prevalence of stroke in the U.S. is approximately 4.8 million with approximately 700,000 additional strokes occurring annually. Approximately 150,000 to 250,000 stroke survivors becoming severely and permanently disabled each year.
A common neurological deficit among stroke survivors, and thus a substantial contributor to post-stroke disability, is aphasia. The loss of, or difficulty with language is extremely debilitating. Recently, there has been an emphasis on the need for intensive aphasia treatment in order to make the long-term neuroplastic changes associated with recovery. However, specific information regarding effective learning parameters is limited.
A number of variables and practice conditions, deriving from motor learning theory, potentially impact the rehabilitation process. Several of these variables have begun to be addressed in the literature, but with conflicting or scant evidence to date. Variables include the type and degree of external cueing, low versus high feedback conditions, task complexity, and practice distribution and schedule.
The purpose of this study is to:
Measures will include independent pre-and post assessments of acquisition, maintenance and generalization of script learning as well as dependent item/cue level measures of progress.
Results and computational models of acquisition, maintenance and generalization will contribute new evidence to support not just the efficacy and delivery of AphasiaScripts, but also the application of practice principles to aphasia treatment in general.
The first part of the study - a cross-over study that evaluates error-free versus error-reducing script training has been done. Below is a description of the second part of the study which evaluates feedback and script complexity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
90 minutes/day, 6 days a week; includes 3 weeks of training
Time frame: Change from baseline to post-treatment in three weeks
For trained script, untrained script, generalization script
Time frame: Change from baseline to post-treatment in three weeks
For trained script, untrained script, generalization script
Shirley Ryan AbilityLab
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01927302
Agrammatism, Agraphia
Chicago, Illinois, United States
View Trial DetailsNCT06891638
Aphasia, Brain Diseases
West Orange, New Jersey, United States
View Trial DetailsNCT05570578
Aphasia, Brain Diseases
Geneva, Canton of Geneva, Switzerland
View Trial DetailsNCT01540383
Aphasia, Behavior
Münster, North Rhine-Westfalia, Germany
View Trial Details